Tuberculosis Cure

Yes, there is a cure for tuberculosis: a combination of antibiotics taken for months. WHO stated in its 2026 fact sheet that TB is preventable and curable. Inactive TB has its own regimens, lasting 3 to 9 months depending on the drugs². WHO added in 2026 that the medicines work only when taken daily for 4 to 6 months¹. For active TB, CDC listed six drugs in 2025: ethambutol, isoniazid, moxifloxacin, rifampin, rifapentine and pyrazinamide². WHO noted in 2026 that TB disease is usually treated with antibiotics and can be fatal without treatment¹.

The regimens themselves are set out step by step. Each one is covered in the guide to tuberculosis treatment in the US.

Tuberculosis is cured by taking several TB drugs together, every dose, until the course ends. The standard course is 6 months: rifampin, isoniazid, pyrazinamide and ethambutol for 2 months, then rifampin and isoniazid for 4. CDC guidance from 2025 tells patients not to miss any doses and not to stop early². Directly observed therapy, in person or by video, is the standard of care³. Under it, a health care worker watches each dose being swallowed and asks about problems or side effects. The first 2 months, the intensive phase, kill actively growing germs and help prevent drug resistance³. Most people feel well after a few weeks, but the germs are still alive, so the medicine must be finished. Each drug is described among the TB medications used in the US.

Curing active tuberculosis takes 4, 6 or 9 months, depending on the regimen and the case. The 4-month rifapentine-moxifloxacin regimen is the shortest for active TB, for people 12 and older. Drug-resistant TB can take months or years to treat². For newly diagnosed TB of the lungs, the 6-month regimen is preferred³. The 4-month regimen lasts 17 weeks and is meant for people who weigh at least 40 kg³. The 9-month regimen is used for a lung cavity with a positive culture after 2 months, among other cases³. The intensive phase should be finished within 3 months, and the full 6-month regimen within 9 months³. The question of how long does tuberculosis last covers the illness itself.

The tuberculosis cure rate is reported as treatment success, which WHO data from 2025 put at 88% for drug-susceptible disease. With a completed regimen, the cure rate for drug-susceptible TB can exceed 95%, a StatPearls review notes. The 88% figure covers people who started treatment in 2023⁴. Success was lower among people living with HIV, at 79%⁴. Children aged 0 to 14 reached 92%⁴.

Yes, drug-resistant tuberculosis is treatable, though the usual first drugs no longer work against it. WHO stated in 2026 that MDR-TB is treatable and curable with other drugs, which cost more and cause more side effects. Multidrug-resistant (MDR) TB resists at least isoniazid and rifampin (CDC, 2025). CDC guidance from 2025 says patients with MDR TB must be referred at once to an expert. BPaLM combines bedaquiline, pretomanid, linezolid and moxifloxacin for rifampin-resistant lung TB, over 6 months, from age 14⁵. BPaL is used when fluoroquinolones cannot be, and 2 years of monitoring follow either regimen⁵. Worldwide, 71% of people who began MDR/RR-TB treatment in 2022 were treated successfully⁴. Only about 2 in 5 people with MDR-TB got treatment in 2024¹. Resistance is rare in the US: CDC reported in 2025 that 115 cases in 2024 were MDR, 1.5% of 7,475 tested. The page on drug-resistant tuberculosis goes into more detail.

No, active tuberculosis needs medicine to clear, and untreated it is fatal in many cases. Inactive TB can stay silent, but about 1 in 10 people with it get sick later if untreated. Treating inactive TB prevents disease in about 90% of cases, CDC reported in 2025. In active TB disease the body cannot stop the germs growing, so the person feels sick and can be contagious (CDC, 2024). A 2011 review put the 10-year death rate of untreated smear-positive TB at about 70%, in HIV-negative people⁷. Reported figures ranged from 53% to 86%⁷. For smear-negative, culture-positive TB, the same review estimated about 20%⁷. Inactive TB is explained on the page about latent tuberculosis.

No, tuberculosis cannot be cured without antibiotics, and no home or herbal remedy replaces them. Food supports recovery, but a 2016 Cochrane review found no evidence that supplements improve treatment outcomes. Food supplements may help people gain weight while they recover (Cochrane, 2016). Vitamin D has not been shown to speed sputum conversion (Cochrane, 2016). WHO guidance from 2025 calls for nutritional assessment and counselling for everyone with TB. It adds food support for people who are undernourished. Herbal products carry their own risk: the rifampin label groups them with alcohol and liver-harming medicines to avoid. Each popular remedy is weighed in the guide to natural remedies for tuberculosis.

Yes, tuberculosis can come back, though most healthy people who finish a full course do not need treating again. Recurrence is either a relapse of the same germs or a new infection with a different strain. A skin or blood test can stay positive after a cure². For that reason, CDC advised in 2025 keeping a written record that you finished treatment. A 2021 review of 145 studies found recurrence at 2.26 per 100 person-years⁸. Relapse made up about 70% of recurrences overall and 83% in places where TB is uncommon⁸. CDC guidance from 2025 says the continuation phase helps cut treatment failure and relapse. With a lung cavity and a positive culture at 2 months, relapse runs about 20%, against 2% with neither⁹. In that case experts extend treatment by 3 months⁹. The page asking whether you can get tuberculosis twice covers reinfection.

Tuberculosis was first cured with an antibiotic after streptomycin was found in the 1940s. A randomized British trial of streptomycin was published in the BMJ in 1948. Used alone, streptomycin could not be relied on to cure TB, because the germs became resistant⁶. Combined with PAS, it worked far better, and later trials added isoniazid⁶. Albert Schatz isolated streptomycin in 1943 in the laboratory of Selman Waksman at Rutgers University (NobelPrize.org). Waksman received the 1952 Nobel Prize in Physiology or Medicine for streptomycin, the first antibiotic effective against TB. The MRC trial ran for 15 months⁶. Its story is told on the page about streptomycin, the first tuberculosis antibiotic.

No, there was no reliable cure before antibiotics, and rest in a sanatorium was the main treatment. Within five years of entering a sanatorium, half of the patients had died (Wellcome Collection, 2022). Hermann Brehmer, a botany student who had TB himself, described the sanatorium cure in 1854 (Barberis, 2017). Patients got complete rest, a balanced diet, fresh air, sunshine and moderate exercise under medical supervision (Martini, 2018). Edward Trudeau opened the Adirondack Cottage Sanitarium at Saranac Lake in 1884 (Trudeau Institute). By 1938 the US had more than 700 sanatoria (Encyclopedia of Arkansas). Danish doctors gave gold salts, as Sanocrysin, from the mid-1920s (Norn, 2011). Enthusiasm faded in the 1930s after controlled trials and reports of toxicity (Norn, 2011). The Trudeau Sanatorium closed in 1954, as antibiotics took over (Trudeau Institute). The history page shows how TB was treated before antibiotics in more detail.

These short answers cover the lungs, the length of treatment, TB outside the lungs and deaths.